Sort
17,288 grants matching “multiple sclerosis”
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
$1,100,000Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2014 · FD
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
$1,100,000Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2015 · FD
Direct RNA sequencing using electo-optical zero mode waveguides and custom click fluorescent nucleotides
$1,099,285Meni Wanunu · Northeastern University · R01 · FY2024 · HG
A Phase III Trial of Lorenzo's Oil in Adrenomyeloneuropathy
$1,098,875Gerald V Raymond · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2007 · HD
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
$1,097,504Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2016 · FD
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$1,096,999Dorothy Anne Cross · Washington University · P01 · FY2010 · NS
SCH: Wearable Multi-Modal Sensing and Stimulation Arrays for Muscle-Aware Exoskeleton Control
$1,095,532Nitin Sharma · North Carolina State University · · FY2021 · CSE
The Role of B cells in the Origin and Progression of Multiple Sclerosis
$1,095,360Stephen L Hauser · University Of California, San Francisco · R35 · FY2024 · NS
MULTICENTER CLINICAL STUDY OF ALS GENETICS
$1,094,656Northwestern University · R01 · FY2000 · NS
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$1,094,640Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS
CHS: Medium: Collaborative Research: Social Learning in Mixed Human-Robot Groups for People with Disabilities
$1,094,043Aman Behal · The University Of Central Florida Board Of Trustees · · FY2014 · CSE
CHRONIC NEUROLOGIC DISEASE PRODUCED BY VIRUS INFECTION
$1,092,921University Of Colorado Denver · P01 · FY2001 · NS
Biomarkers and Pathogenesis of Multiple Sclerosis: From Mouse to Human
$1,092,899Dorothy Anne Cross · Washington University · P01 · FY2009 · NS
Pathophysiology of genetically defined dementia and neurodegeneration: Defining therapeutic targets and pathways
$1,091,444Matthew D Disney · Scripps Florida · P01 · FY2020 · NS
Glycolipid Presentation by CD1d
$1,091,369University Of Chicago · P01 · FY2003 · AI
A Haplotype Map for Multiple Sclerosis
$1,089,455Stephen L Hauser · University Of California, San Francisco · R01 · FY2010 · NS
NIMH Instrumentation Core Facility
$1,088,919George Dold · National Institute Of Mental Health · ZIC · FY2013 · MH
Neural Control of Breathing
$1,088,345Jack L. Feldman · University Of California Los Angeles · R35 · FY2025 · HL
Neural Control of Breathing
$1,088,345Jack L. Feldman · University Of California Los Angeles · R35 · FY2024 · HL
ALZHEIMERS RESEARCH PROJECT: Developing Extraceullar Vesicle biomarkers for clinical and preclinical AD/ADRD
$1,086,297Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2025 · AG
ALZHEIMERS RESEARCH PROJECT / CLINICAL PROJECT: Mechanistic and clinical studies in Alzheimer's disease and related disorders
$1,086,297Dimitrios Kapogiannis · National Institute On Aging · ZIA · FY2025 · AG
CHRONIC NEUROLOGIC DISEASE PRODUCED BY VIRUS INFECTION
$1,083,736University Of Colorado Denver · P01 · FY2000 · NS
Center for Quantitative Biology: a focus on âomicsâ, from organisms to single cells Supplement 4
$1,082,397Michael L Whitfield · Dartmouth College · P20 · FY2024 · GM
Sensory motor transformations in human cortex
$1,082,090Richard A Andersen · California Institute Of Technology · U01 · FY2021 · NS
Environmental biosensors in the oligodendrocyte lineage
$1,081,024Patrizia Casaccia · Advanced Science Research Center · R35 · FY2019 · NS